2009년도 1학기 우수의과학자 초청 세미나 12주차
- Speaker : 김동환 박사(삼성의료원 / 성대 의대)
- Topic : Single nucleotide polymorphism in hematologic disease
- Date : 2009년 5월 27일(수) 오전 9:30
- Location : 함춘강의실
- Inquiry : 02-740-8095
주요 발표 논문
Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia. Blood. 2009
The single nucleotide polymorphisms involving bcl-2 / interleukin-10 mediated pathway predict the outcomes of rituximab plus CHOP chemotherapy in diffuse large B-cell lymphoma. Clin Cancer Res. in press
No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia. Cancer. 2008
Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia. 2007
FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma. Blood. 2006
